Pathogenesis of Psoriasis in the "omic" Era. Part IV. Epidemiology, Genetics, Immunopathogenesis, Clinical Manifestation and Treatment of Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic, progressive, inflammatory arthropathy associated with psoriasis as well as a complex pathogenesis. Genetic and environmental factors trigger the development of the immune-mediated auto-inflammatory response in different sites: skin, bone marrow, entheses and synovial tissues. Studies of the last two decades have changed the view of PsA from a mild, non-progressive arthritis to an inflammatory systemic disease with serious health consequences, not only associated with joint dysfunction, but also with an increased risk of cardiovascular disease and socioeconomic consequences with significantly reduced quality of life. The joint damage starts early in the course of the disease, thus early recognition and treatment with modern biological treatments, which may modify the natural history and slow down progression of this debilitating disease, is essential for the patient long-term outcome.

Citing Articles

Management of psoriatic arthritis: a consensus opinion by expert rheumatologists.

DAngelo S, Atzeni F, Benucci M, Bianchi G, Cantini F, Caporali R Front Med (Lausanne). 2023; 10:1327931.

PMID: 38098852 PMC: 10720668. DOI: 10.3389/fmed.2023.1327931.

Evaluation of clinical efficacy of tumor necrosis factor‑α inhibitors in treatment of distal extremity swelling with pitting edema in psoriatic arthritis of inadequate response to conventional therapy: A 10‑year retrospective study.

Zhao C, Liu B, Yao Y, Yang K, Zang B, Liu B Exp Ther Med. 2023; 25(6):263.

PMID: 37206568 PMC: 10189727. DOI: 10.3892/etm.2023.11962.

The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis.

Wierzbicka J, Piotrowska A, Purzycka-Bohdan D, Olszewska A, Nowak J, Szczerkowska-Dobosz A Int J Mol Sci. 2021; 22(23).

PMID: 34884710 PMC: 8657669. DOI: 10.3390/ijms222312907.

Fuzhenghefuzhiyang Formula (FZHFZY) Improves Epidermal Differentiation Suppression of the Akt/mTORC1/S6K1 Signalling Pathway in Psoriatic Models.

Lu Y, Chen H, Zhang J, Tang B, Zhang H, Ma C Front Pharmacol. 2021; 12:650816.

PMID: 34456715 PMC: 8386017. DOI: 10.3389/fphar.2021.650816.

References

Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y . Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001; 28(3):554-9. View

Olivieri I, Barozzi L, Favaro L, Pierro A, De Matteis M, Borghi C . Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum. 1996; 39(9):1524-8. DOI: 10.1002/art.1780390912. View

Gisondi P, Tinazzi I, El-Dalati G, Gallo M, Biasi D, Barbara L . Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis. 2007; 67(1):26-30. DOI: 10.1136/ard.2007.075101. View

Moll J, WRIGHT V . Familial occurrence of psoriatic arthritis. Ann Rheum Dis. 1973; 32(3):181-201. PMC: 1006078. DOI: 10.1136/ard.32.3.181. View

Puig L, Julia A, Marsal S . The pathogenesis and genetics of psoriasis. Actas Dermosifiliogr. 2013; 105(6):535-45. DOI: 10.1016/j.ad.2012.11.006. View

Mease P, Coates L, Helliwell P, Stanislavchuk M, Rychlewska-Hanczewska A, Dudek A . Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. Lancet. 2018; 392(10162):2367-2377. DOI: 10.1016/S0140-6736(18)32483-8. View

Bowes J, Flynn E, Ho P, Aly B, Morgan A, Marzo-Ortega H . Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Ann Rheum Dis. 2010; 69(12):2199-203. PMC: 3002763. DOI: 10.1136/ard.2010.130575. View

De Angelis R, Salaffi F, Grassi W . Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol. 2007; 36(1):14-21. DOI: 10.1080/03009740600904243. View

Tan A, Benjamin M, Toumi H, Grainger A, Tanner S, Emery P . The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study. Rheumatology (Oxford). 2006; 46(2):253-6. DOI: 10.1093/rheumatology/kel214. View

10.

Aterido A, Canete J, Tornero J, Ferrandiz C, Pinto J, Gratacos J . Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann Rheum Dis. 2018; 78(3). DOI: 10.1136/annrheumdis-2018-214158. View

11.

Tateiwa D, Yoshikawa H, Kaito T . Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review. Cells. 2019; 8(8). PMC: 6721572. DOI: 10.3390/cells8080818. View

12.

Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen C, Bull S . Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2011; 71(1):50-5. DOI: 10.1136/ard.2011.155044. View

13.

Nair R, Callis Duffin K, Helms C, Ding J, Stuart P, Goldgar D . Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009; 41(2):199-204. PMC: 2745122. DOI: 10.1038/ng.311. View

14.

Soare A, Weber S, Maul L, Rauber S, Gheorghiu A, Luber M . Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis. J Immunol. 2018; 200(4):1249-1254. DOI: 10.4049/jimmunol.1700596. View

15.

Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg D . HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 2011; 64(4):1134-44. DOI: 10.1002/art.33415. View

16.

Sukhov A, Adamopoulos I, Maverakis E . Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review. Clin Rev Allergy Immunol. 2016; 51(1):87-99. PMC: 6080719. DOI: 10.1007/s12016-016-8529-8. View

17.

Candia L, Marquez J, Hernandez C, Zea A, Espinoza L . Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?. J Rheumatol. 2006; 34(2):374-9. View

18.

Huffmeier U, Uebe S, Ekici A, Bowes J, Giardina E, Korendowych E . Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet. 2010; 42(11):996-9. PMC: 2981079. DOI: 10.1038/ng.688. View

19.

Narvaez J, Narvaez J, de Albert M, Gomez-Vaquero C, Nolla J . Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease?. Semin Arthritis Rheum. 2012; 42(3):234-45. DOI: 10.1016/j.semarthrit.2012.03.016. View

20.

Blumberg B, Bunim J, CALKINS E, PIRANI C, Zvaifler N . ARA NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE). Arthritis Rheum. 1964; 7:93-7. DOI: 10.1002/art.1780070113. View